Lawrence P. Guiheen - 09 Jun 2025 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Lawrence P. Guiheen, by Adam S. Grossman as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
09 Jun 2025
Net transactions value
-$419,200
Form type
4
Filing time
11 Jun 2025, 21:00:21 UTC
Previous filing
23 May 2025
Next filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Guiheen Lawrence P. Director C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY /s/ Lawrence P. Guiheen, by Adam S. Grossman as Attorney-in-fact 11 Jun 2025 0001554353

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Sale $419,200 -20,000 -17% $20.96 94,830 09 Jun 2025 Direct F1
holding ADMA Common Stock 50,990 09 Jun 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes, as of the transaction date, (i) 10,889 restricted stock units granted on February 19, 2025, which vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of such vesting date; and (ii) 83,941 shares of common stock owned by the Reporting Person.
F2 Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1.